Favipiravir Tablets 400 mg Manufacturer Supplier & PCD Franchise

PCD Pharma Company in Ahmednagar
September 8, 2021
Methylprednisolone Tablet Manufacturer Supplier & PCD Franchise
September 17, 2021

Favipiravir is a synthetic prodrug used in the treatment of viral infections such as influenza, SARS-COV-2. Favipiravir starts functioning by the action of a certain enzyme and it then interferes in the functioning of the viral cells, prohibiting the further growth of the infection-causing viral cell. Favipiravir Tablet is not a metabolized medicine rather it is metabolized within the human body after administration.

Favipiravir Tablet was initially used to treat widespread influenza in Japan in 2014. It was successful in treating various viral infections when used with proper precautions. Due to the non-availability of medicine to treat the new coronavirus infection, doctors have tried using several existing medicines and found a few of them to be really helpful. One of them is Favipiravir. This drug was used in Wuhan for the first time to treat SARS-CoV-2 infection. Thereafter, several countries have given emergency approvals for the use of Favipiravir in the treatment of coronavirus infection.

This particular medicine has been given authorization by the Drug Controller General of India (DCGI) to be used in the treatment of Covid-19 under emergency provisions. It is used to treat mild to moderate COVID-19 infection in patients. It acts on the viral cells and helps to overcome symptoms of the virus.

According to a news report, patients cleared COVID-19 infection faster after taking favipiravir.

Precautions while using Favipiravir Tablet

Favipiravir has to be used after consulting the doctor, self-medication is not motivated in this case. The patient should discuss complete medical history with the doctor and thereafter doctor will prescribe whether Favipiravir is to be used or not.

  • Pregnant or breastfeeding women or those planning for pregnancy should not take this medicine as it has a direct impact on the growing embryo
  • Men taking Favipiravir should refrain from sexual intercourse without protection during the administration of this medicine as it mixes up with the semen which might affect the growth of the baby produced with that semen.
  • Patients having a history of liver or kidney-related diseases should avoid taking this medicine.

There could be several side effects of this medicine as well such as diarrhea, excess uric acid production, decreased white blood cell count, psychiatric problems, increased liver enzymes, etc. Thus it is advised to consult a doctor before taking Favipiravir Tablet.

Favipiravir Tablets 400 mg Manufacturer Supplier & PCD Franchise

Contact us for Manufacturing or Supply or PCD Pharma Franchise for Favipiravir Tablets 400 mg | Sanify Healthcare

Sanify Healthcare is an ISO-certified manufacturer of Favipiravir Tablets 400 mg. We offer to supply Favipiravir Tablet 400mg to dealers throughout the nation. Sanify Healthcare is a well-trusted brand for manufacturing standard quality Favipiravir medicine of 400 mg packing under the name Aniflovir 400. We have state-of-the-art manufacturing facilities. Our Quality Control team is dedicated to ensuring the supreme quality of the products being manufactured. The manufactured tablets undergo several tests to ensure the safety and efficacy of the product.

We offer a PCD Pharma Franchise for a wide range of highly effective pharma products. We offer several benefits to our franchise partners.

  • well certified manufacturing and research facilities
  • drugs approved by DCGI and FSSAI
  • on-time delivery of ordered products
  • cost-effective manufacturing processes
  • Complete quality check of the products being manufactured
  • additional benefits to franchise partners such as monopoly rights, promotional tools, etc.

Get in touch with us at the earliest to take benefit of such an experienced manufacturer of Favipiravir Tablet.

Contact Details

Name: Sanify Healthcare

Address: Sanify Healthcare Private Limited, Plot No 1323, JLPL,  Industrial Area, Sector – 82, Mohali  – 160055, Punjab, India

Phone: 9216222788

Email: sanify@sanifyhealthcare.com

Enquire Us
close slider